Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2011, Article ID 691587, 6 pages
Research Article

MMP-Activated Fluorescence Imaging Detects Early Joint Inflammation in Collagen-Antibody-Induced Arthritis in CC-Chemokine Receptor-2-Null Mice, In-Vivo

1Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA
2Veterans Administration Center for Research on AIDS and HIV-1 Infection and South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, TX, USA

Received 8 February 2011; Revised 12 March 2011; Accepted 18 March 2011

Academic Editor: Bernhard Rintelen

Copyright © 2011 Jessica M. Ibarra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. C. Lawrence, C. G. Helmick, F. C. Arnett et al., “Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States,” Arthritis and Rheumatism, vol. 41, no. 5, pp. 778–799, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. C. H. MacLean, R. Louie, B. Leake et al., “Quality of care for patients with rheumatoid arthritis,” Journal of the American Medical Association, vol. 284, no. 8, pp. 984–992, 2000. View at Google Scholar · View at Scopus
  3. O. Sangha, “Epidemiology of rheumatic diseases,” Rheumatology, vol. 39, no. 2, pp. 3–12, 2000. View at Google Scholar · View at Scopus
  4. F. M. Brennan, A. Jackson, D. Chantry, R. Maini, and M. Feldmann, “Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis,” Lancet, vol. 2, no. 8657, pp. 244–247, 1989. View at Google Scholar · View at Scopus
  5. W. P. Arend and J. M. Dayer, “Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 2, pp. 151–160, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. M. P. Quinones, S. K. Ahuja, F. Jimenez et al., “Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis,” Journal of Clinical Investigation, vol. 113, no. 6, pp. 856–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Quinones, C. A. Estrada, Y. Kalkonde et al., “The complex role of the chemokine receptor CCR2 in collagen-induced arthritis: implications for therapeutic targeting of CCR2 in rheumatoid arthritis,” Journal of Molecular Medicine, vol. 83, no. 9, pp. 672–681, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. R. Frade, M. Mellado, G. Del Real, J. C. Gutierrez-Ramos, P. Lind, and C. Martinez-A. C., “Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells,” Journal of Immunology, vol. 159, no. 11, pp. 5576–5584, 1997. View at Google Scholar · View at Scopus
  9. A. Katrib, P. P. Tak, J. V. Bertouch et al., “Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis,” Rheumatology, vol. 40, no. 9, pp. 988–994, 2001. View at Google Scholar · View at Scopus
  10. A. B. Blom, P. L. Van Lent, S. Libregts et al., “Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3,” Arthritis and Rheumatism, vol. 56, no. 1, pp. 147–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Dale and D. Porter, “Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritis,” Best Practice & Research Clinical Rheumatology, vol. 24, no. 4, pp. 443–455, 2010. View at Google Scholar